InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Friday, 04/23/2021 3:09:47 PM

Friday, April 23, 2021 3:09:47 PM

Post# of 233066
CD16 being done in India because patients are recovering too effectively in the US? Seriously? Criticals in the CD12 had a mortality of 47% in the placebo arm and 38% in the leronlimab arm. But now too many are surviving?

I bet a lot of the CD12 trial sites told CytoDyn that they weren't interested in participating in the CD16.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News